Saturday, September 26, 2020

Tag: coronavirus

Healthcare to reduce the cost of medical – It’s not just...

Marble Arch Research notes that PetVivo (OTCQB: PETV)achieved a major funding milestone last month, removing the main obstacle to its product commercialization goals. Commercial production of its disruptive osteoarthritis treatment device, Kush®, for canines and equines, a market we estimate is worth ~$3BN in the US alone, is due to commence in September 2020.

Covid-19 brings out a fitness craze and brings up Fitness stocks

Glucose Health, Inc. (OTC Pink: GLUC) just announced unprecedented consumer demand and 2nd quarter fiscal 2020 sales. 2nd quarter fiscal 2020 revenues increased 186% compared to the 2nd quarter of fiscal 2019 – in fact, Q2 2020 revenues were just $7,140 short of tripling 2nd quarter 2019 revenues.

Top Stocks in the Education Space

In light of Early’s article, let us consider another education company: China Education Resources Inc. ("CER” or “the Company”). CER is perfectly poised to cater towards the intensified e-learning market demands which have arisen as a direct result of the COVID-19 pandemic. Based in Vancouver, Canada, CER is a publicly-listed ed-tech company (TSX-V:CHN and OTCQB:CHNUF) with leading technology in intelligent system and contents.

Why VBI Vaccines (NASDAQ: VBIV) Could Be a Contrarian Investor’s Dream

While the list of those garnering the most attention read like the usual suspects, there’s probably one biotech firm you haven’t heard of, VBI Vaccines (NASDAQ:VBIV). While VBIV stock soared to multi-year highs around mid-July, shares have found themselves plummeting back to earth. As several now well-known vaccine companies have entered into late-stage clinical trials for their Covid-19 candidates, the other, smaller names have lost their luster.

Stocks to be in before 2021

Glucose Health, Inc. is an under-the-radar company whose GLUCODOWN® products are found in major national pharmacy chains including Walmart (NYSE: WMT), CVS Health (NYSE: CVS) and even online at Amazon.com (NASDAQ: AMZN) yet is still trading below a $20 million valuation.

The Best Social Distancing Stocks

Epazz, Inc. (OTC Pink: EPAZ) is currently sitting on its 100-day moving average and looks like it could rebound before hitting any resistance to about $.15 per share depending on how its Q3 comes in. If the stock could break resistance its next pivot is sitting at just under $.55 per share.

Glucose Health, Inc. (GLUC) Unveils GLUCODOWN® “Enhanced Water” Drink Mix Retail...

Glucose Health, Inc. (GLUC) Unveils GLUCODOWN® "Enhanced Water" Drink Mix Retail Packaging and 2020 Launch Date

The Stocks to own after the Presidential Election

Joe Biden wants to put the U.S. on track to achieve "a 100% clean energy economy and Brookfield Renewable Partners (NYSE:BEP) stands out as one stock positioned to perform especially well as three-quarters of the company's funds from operations (FFO) comes from its hydroelectric facilities.

Epazz, Inc. (EPAZ) – Healthcare, Government Contracts and now Education

Under Mayor Bill de Blasio’s proposal in New York City, schools are reopening using a hybrid model, under which students will attend in-person classes only a few days in a week. The schools limit classroom capacity to 12 students to comply with social distancing recommendations from health experts and the CDC. DeskFlex will benefit from these recommendations because our software makes it possible for schools to maintain capacity limits for each classroom, social distancing protocols and anti-coronavirus measures.

Epazz (EPAZ) DeskFlex Room Booking Software Is Receiving Increased Demand From...

Epazz DeskFlex Room Booking Software Is Receiving Increased Demand From Universities and Colleges Struggling to Reopen After COVID-19 Lockdowns DeskFlex Course Scheduling Software for universities receives more requests from schools, colleges and universities to reopen safely amidst the coronavirus pandemic.